Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,887
Total Claims
$510K
Drug Cost
534
Beneficiaries
$954
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+100%
Opioid rate vs peers
5.1% vs 2.6% avg
-11%
Cost per patient vs peers
$954 vs $1,068 avg
+15%
Brand preference vs peers
10.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
5.1%
Opioid Rate
303
Opioid Claims
$4,685
Opioid Cost
4.6%
Long-Acting Rate
Brand vs Generic
Brand: 605 claims · $383K
Generic: 5,247 claims · $126K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 44 | $74K |
| Apixaban | 58 | $62K |
| Empagliflozin | 41 | $42K |
| Fluticasone/Umeclidin/Vilanter | 29 | $36K |
| Semaglutide | 11 | $23K |
| Brexpiprazole | 13 | $21K |
| Sitagliptin Phosphate | 23 | $20K |
| Rivaroxaban | 12 | $16K |
| Cyclosporine | 13 | $8,849 |
| Evolocumab | 11 | $5,980 |
| Atorvastatin Calcium | 358 | $5,355 |
| Levothyroxine Sodium | 233 | $4,322 |
| Fluticasone Propion/Salmeterol | 12 | $3,956 |
| Diltiazem Hcl | 15 | $3,496 |
| Rosuvastatin Calcium | 95 | $3,405 |
Prescribing Profile
Patient Profile
72
Avg Age
64%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About